Feasibility of Empowerment Group Therapy on Ukrainian Adult Outpatients
The Effects of Empowerment Group Therapy on Ukrainian Adult Outpatients Located Inside the Country During the War
1 other identifier
interventional
55
1 country
1
Brief Summary
This single-arm pilot study aims to explore the feasibility and acceptability of the culturally adapted, Ukrainian version of the Empowerment Group Therapy (Wiechers, 2023) manual and accompanying workbook for the Ukrainian population affected by the ongoing war. Feasibility will be evaluated based on participant retention. Acceptability will be assessed through questionnaires and qualitative feedback. The study also gathers preliminary data on the effectiveness of the intervention by assessing changes in quality of life, stress, symptoms of anxiety, depression, PTSD, and somatization. Overall, it seeks to explore the relevance and impact of group-based resilience therapy in a conflict-affected setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2024
CompletedFirst Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJuly 3, 2025
June 1, 2025
9 months
June 18, 2025
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Feasibility of the intervention
Feasibility will be indexed by inclusion rate of participants to the study.
Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)
Feasibility of the intervention
Feasibility will be indexed by participants attendance of the group therapy sessions (\>80% of sessions).
Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)
Feasibility of the intervention
Feasibility will be indexed by droup-out rate (\<20% of participants).
Post-Intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)
Acceptability of the intervention
Acceptability will be assessed by the rate of intervention completion (\>80% complete all sessions).
Post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)
Acceptability of the intervention
Acceptability will be assessed by using the Client Satisfaction Questionnaire (Attkisson \& Zwick, 1982).
Post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline)
Secondary Outcomes (6)
Stress, anxiety and depression
At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)
Depressive symptoms
At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)
PTSD Symptoms
At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)
Somatic symptom burden
At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)
Health-related Quality of Life
At baseline, post-intervention (after completion of 10 group psychotherapy sessions; 10 to 11 weeks from baseline), and follow-up (4 weeks after last group therapy session)
- +1 more secondary outcomes
Study Arms (1)
CBT-based group therapy intervention "Empowerment"
EXPERIMENTAL10 CBT-based psychotherapeutic group sessions will be held weekly, either in person or online, through trained psychiatrists or psychotherapists from the Department of Medical Psychology, Psychosomatic Medicine, and Psychotherapy at Bogomolets National Medical University. During the first group session, participants will receive the workbook "Empowerment" ("Опора та стійкість"), which is to be completed at home between sessions as homework. Each session will include an assessment of the participants' general current condition, their engagement in the psychotherapeutic interventions, group dynamics, and more.
Interventions
Empowerment is a manualized, culturally sensitive treatment program. The treatment is based on a modular principle that transdiagnostically targets major symptom domains (e.g. stress, depression, anxiety), and can be flexibly adapted to individual mental health conditions of clients who participate in this program. The intervention is designed as a psychological group intervention for resource-limited settings and scalable for different formats (i.e. in-person, online, hybrid) to be feasible under the unstable conditions of war (e.g. missile attacks, power outrages). Key therapeutic elements are psychoeducation, emotion regulation strategies, problem solving and building coping skills. The activation of individual and culture-specific resources as well as building self-help skills are at focus of the treatment.
Eligibility Criteria
You may qualify if:
- Civilians
- years of age or older
- Residency in Ukraine at the onset of the full-scale war in Ukraine and at the time of the study
- Ability to participate in in-person or online sessions
- Ability to participate in online sessions, including communication via smartphone chat
- Speaks Ukrainian or Russian
- Presence of depression, anxiety, stress according to DSM-5 criteria, or psychological distress directly or indirectly caused by the war (other conditions may be included if deemed appropriate by a physician)
- Moderate severity of symptoms on the depression, anxiety, or stress subscale of the DASS-21
- Anyone who, upon being placed on the waiting list, recognizes a need for help and support is eligible to participate
- Signed informed consent form
You may not qualify if:
- Lack of informed consent
- Diagnosis of schizophrenia, autism spectrum disorders, degenerative disorders, or significant cognitive impairments
- Use of psychoactive substances and alcohol
- Acute risk of suicide
- Ongoing psychotherapy or psychotherapy within the past 3 months
- Psychopharmacological treatment (at the discretion of the therapist during screening)
- Current inpatient treatment
- Incomplete screening questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Medical University Bogomolets
Kyiv, Kyiv Oblast, Ukraine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident/research associate
Study Record Dates
First Submitted
June 18, 2025
First Posted
July 3, 2025
Study Start
November 5, 2024
Primary Completion
August 1, 2025
Study Completion
September 1, 2025
Last Updated
July 3, 2025
Record last verified: 2025-06